US FDA Spurns Merck Contraceptive, Glaucoma Drug

The FDA has declined to approve an oral contraceptive and a glaucoma treatment being developed by Merck & Co Inc, but the U.S. drugmaker did not disclose details of the agency's concerns.
Reuters Health Information

Full Story →